In Depth 5 Dec 2025 The biggest biotech funding rounds in November 2025 The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. December 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 5 Dec 2025Cracking Cancer’s Code: Transforming Research with Novel Cancer Models This week’s guest is Mark Lanasa of BeOne Medicines and we will discuss their novel cancer models and unique in-house R&D approach. December 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Playbooks Produced by Inpart 4 Dec 2025Alliance management operations playbook: The path to smarter, streamlined alliance management This playbook serves as a blueprint for deploying operational strategies that empower Alliance Management teams to unlock the full potential of every partnership. December 4, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Dec 2025 Greener pastures for biopharma? Biotechs in Ireland causing a stir The biopharma ecosystem in Ireland incudes big pharmas as well as smaller native biotechs making a name in the region. December 3, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Igyxos Biotherapeutics 2 Dec 2025 Rethinking infertility treatment: Treating couples, not just women Igyxos’ IGX12 brings a fresh approach to infertility treatment, aiming to improve outcomes for both men and women. December 2, 2025 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 2 Dec 2025 Vandria reports VNA-318’s first-in-human data in Alzheimer’s Delve into Vandria’s technology and its Alzheimer’s candidate, VNA-318, the first mitophagy-based candidate in Alzheimer’s to reach the clinic. December 2, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Dec 2025 Stem cell therapy’s avant-garde: Eight companies leading the way Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field. December 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2025 Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. November 28, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 28 Nov 2025Curing cancer: Daiichi Sankyo’s ambitious ADC approach In today’s episode, Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo will discuss the company’s approach November 28, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 26 Nov 2025 Beyond GLP-1s: is there a new wave of metabolic disease treatments? A new wave of metabolic disease treatments beyond GLP-1 agonists is emerging to address the unmet needs of patients. November 26, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Nov 2025 11 neuroscience biotech companies you should know about Learn more about 11 of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions. November 25, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email